Predicine is a global molecular insights company committed to advancing precision medicine in oncology and infectious disease diagnostics. Predicine is developing proprietary technologies for cell-free DNA and cell-free RNA liquid biopsy to enable minimally invasive molecular diagnoses for early cancer detection, treatment selection, therapy response, minimal residual disease monitoring, and disease progression. The Predicine portfolio includes blood, urine, and tissue based NGS assays designed for globally harmonized use in research, clinical investigation, and companion diagnostic (CDx) development. Through its business operations in Silicon Valley, Houston, Chicago, Shanghai, Beijing, Suzhou, and Harbin, Predicine is partnering and collaborating with leading biopharma companies, institutions, and governments to support personalized healthcare on a global scale. Further information is available on the company websites, http://www.predicine.com. Stay in touch on LinkedIn or @Predicine on Twitter.
Site |
Badges |
|
Predicine ATTN Specimen Receiving
3555 Arden Rd
Hayward, California, 94545
United States
|
|
|
Predicine
3555 Arden Rd
Hayward, California, 94545
United States
|
|
|
Predicine
3555 Arden Road
Hayward, CA, 94545
United States
|
|
|
Predicine
3555 Arden Road
Hayward, CA, 94545
United States
|
|
|
Predicine
Predicine Oncology USA c/o Pharma Samples
Hayward, CA, 94545
United States
|
|
|
Predicine
Predicine Oncology USA c/o Pharma Samples
Hayward, CA, 94545
United States
|
|